Insider plans sale of 5,000 ACT common shares
Robert Restrepo has filed a notice of proposed sale of 5,000 shares of the issuer’s common stock on NASDAQ through Fidelity Brokerage Services LLC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Robert Restrepo has filed a notice of proposed sale of 5,000 shares of the issuer’s common stock on NASDAQ through Fidelity Brokerage Services LLC. The filing lists an aggregate market value of $214,750.00 for these shares and an approximate sale date of February 11, 2026. As context, the number of common shares outstanding is shown as 144,395,767. Restrepo acquired the 5,000 shares in an open market purchase from the issuer on September 16, 2021, paid in cash.
The notice also discloses that during the past three months, Restrepo sold 2,562 and 7,438 common shares on November 18 and 19, 2025, for gross proceeds of $95,848.92 and $278,106.82, respectively. By signing, the seller represents that he is not aware of undisclosed material adverse information about the issuer’s operations.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does this Form 144 filing disclose for ACT?
What representation does the seller make about ACT’s information in this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.